Close Menu
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
What's Hot

Bigger tax refunds are coming for 2026 — what it means for the economy

January 14, 2026

Crypto-friendly lender Old Glory to go public through SPAC

January 14, 2026

Best Free Accounting Software for Home and Personal Use

January 14, 2026
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Smart SpendingSmart Spending
Subscribe
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
Smart SpendingSmart Spending
Home»Finance News»Stocks making the biggest moves midday: JPM, MRNA, BA, CAH
Finance News

Stocks making the biggest moves midday: JPM, MRNA, BA, CAH

January 14, 2026No Comments3 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Stocks making the biggest moves midday: JPM, MRNA, BA, CAH
Share
Facebook Twitter LinkedIn Pinterest Email

Check out some of the companies making the biggest moves midday: JPMorgan Chase — The largest bank in the U.S. dropped more than 3%, trading near session lows, after investment banking fees fell, missing expectations. JPM’s chief financial officer signaled that the banking industry could push back against President Donald Trump’s call for a one-year 10% cap on credit card interest rates. Chipotle Mexican Grill — The fast-casual chain fell more than 3% after reaffirming its 2025 guidance, which points to a low single-digit percentage decline in comparable store sales. Chipotle named an interim chief marketing officer to replace the departing Chris Brandt. Moderna – Shares jumped more than 14%. Speaking at JPMorgan’s health-care conference, Moderna CEO Stéphane Bancel projected the company’s 2025 sales to land at roughly $1.9 billion, topping the midpoint of its early guidance. L3Harris Technologies — The defense contractor added 1% after partnering with the Defense Department to increase solid rocket motor capacity and pursuing an initial public offering of its missile business in the second half of 2026. Under the agreement, the U.S. would invest in the business through a $1 billion convertible preferred that would convert to common stock after an IPO. Boeing — The aerospace company rose more than 3% after it outsold Airbus in 2025 for the first time since 2018. In December, Boeing logged net orders for 174 planes, including more than 100 737 Maxes for Alaska Airlines. Boeing delivered 63 jetliners to customers last month. Option Care Health — The provider of at-home or non-hospital infusion services jumped 10%. Option Care released preliminary fourth-quarter results , issued initial 2026 financial guidance and doubled its buyback authorization to $1 billion. Cardinal Health — The drug distributor raised full-year guidance , sending shares nearly 4% higher. Cardinal expects adjusted earnings of at least $10 per share, above prior guidance of $9.65 to $9.86 a share. Delta Air Lines — The airline fell more than 3% after posting mixed fourth-quarter results . The airline earned an adjusted $1.55 per share, beating an LSEG consensus of $1.53 per share. Revenue of $14.61 billion, however, was just below a $14.69 billion estimate. Intel , AMD — KeyBanc upgraded both chip stocks to overweight, saying they each have upside of more than 30% thanks to a memory chip supercycle and outsized data center demand. Intel advanced nearly 8%, while AMD gained 6%. Travere Therapeutics — The biopharma stock tumbled 32% after receiving additional information requests from the FDA to characterize the clinical benefit of a drug to treat kidney disorder. PAR Technology — Shares rose more than 2% after announcing that Papa Johns is using foodservice technology from PAR Technology across its restaurants. Revvity — The health sciences company rallied almost 4% after releasing preliminary fourth-quarter revenue of $772 million, topping the $757 million expected by analysts polled by FactSet. Revvity said it expects its full-year adjusted earnings per share to exceed the upper end of prior guidance of $4.90 to $5 per share. — CNBC’s Michelle Fox, Fred Imbert, Christina Cheddar-Berk and Darla Mercado contributed reporting

See also  Trump ‘big beautiful’ bill gives top 1% biggest tax cuts in these states

Source link

Biggest CAH JPM Making midday Moves MRNA stocks
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous ArticleCiti to cut about 1,000 jobs this week as Fraser trims costs
Next Article 5  tips for researching and analyzing a cryptocurrency

Related Posts

Bigger tax refunds are coming for 2026 — what it means for the economy

January 14, 2026

As enhanced ACA subsidies lapse, millions may drop health insurance

January 13, 2026

Warren Buffett still searching for big elephant deal in his final time as Berkshire CEO

January 13, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Most of $124 trillion ‘great wealth transfer’ to go to women: Studies

March 14, 2025

Mobile app adds bond trading

June 20, 2025

NY Attorney General sues EWA providers DailyPay, MoneyLion | PaymentsSource

April 16, 2025
Ads Banner

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

Stay informed with our finance blog! Get expert insights, money management tips, investment strategies, and the latest financial news to help you make smart financial decisions.

We're social. Connect with us:

Facebook X (Twitter) Instagram YouTube
Top Insights

Bigger tax refunds are coming for 2026 — what it means for the economy

January 14, 2026

Crypto-friendly lender Old Glory to go public through SPAC

January 14, 2026

Best Free Accounting Software for Home and Personal Use

January 14, 2026
Get Informed

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

© 2026 Smartspending.ai - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.